Academic Journal
Q3Medicine Plus
About Medicine Plus
Medicine Plus is a scholarly journal published by KeAi Publishing Communications Ltd.. SCImago 2025 lists it in Q3, with an SJR of 0.452 and H-index of 6.
Coverage: 2024-2026. Research categories: Medicine (miscellaneous) (Q3).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2025-02-21. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Ubiquitin and proteasome pathways; Endoplasmic Reticulum Stress and Disease; Alzheimer's disease research and treatments; Functional Brain Connectivity Studies; Protein Degradation and Inhibitors; Dementia and Cognitive Impairment Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-01. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Rewiring ER-associated degradation for selective elimination of transmembrane proteins
Zuoren Wang
2026-09 · DOI: 10.1016/j.medp.2026.100168The evolving landscape of mRNA-LNP medicine: advances, challenges, and future perspectives
Yi Song, Zhangchi Dongye, Yuzhang Wu, Jian Li et al.
2026-09 · DOI: 10.1016/j.medp.2026.100154The hidden protection of maternal-induced immunity in neonates
Shunjiang Zeng, Shuqin Zeng, Shaopu Wang
2026-09 · DOI: 10.1016/j.medp.2026.100153Engineered microbe-based micro/nanorobots for interventional therapy of luminal cancers
Li Wang, Tianze Du, Nana Ran, Yong Kang et al.
2026-09 · DOI: 10.1016/j.medp.2026.100156LRP8: the cellular entry receptor for yellow fever virus
Miao Mei
2026-09 · DOI: 10.1016/j.medp.2026.100152Deep brain stimulation: from mechanism to application
Yanhao Zhao, Zimeng Huang, Guanyu Zhu, Yingchuan Chen et al.
2026-09 · DOI: 10.1016/j.medp.2026.100161Microbial control of the host metabolic valve for BCAA disposal
Siyan Che, Xia Xu, Jianjun Li, Dandan Han et al.
2026-09 · DOI: 10.1016/j.medp.2026.100157Axial length-stratified cataract phenotypes revealed by automated lens density quantification from IOL Master 700
Yue Wen, Shunkang Wu, Shenglin Yin, Qiong Xu et al.
2026-09 · DOI: 10.1016/j.medp.2026.100162From passive loading to network formation: click clotting inspires the next generation of bone repair materials
Jiaqi Yin, Baikun Liu, Wenguo Cui
2026-09 · DOI: 10.1016/j.medp.2026.100158Food preservative intake and cancer risk: a commentary on evidence from a large prospective cohort study
Xingyu Zhu, Yunfeng Ni, Mingya Zhang, Huiping Li et al.
2026-09 · DOI: 10.1016/j.medp.2026.100155Revisiting selenium in osteoarthritis: from nutritional deficiency to targeted therapeutic opportunities
Jiacheng Liu, Zhenglin Zhu, Yi Xie, Tianfeng Chen et al.
2026-09 · DOI: 10.1016/j.medp.2026.100159Toward a global cradle brain health initiative
Zhexian Sun, Jian Huang, Hongjian He, Xi-Nian Zuo et al.
2026-09 · DOI: 10.1016/j.medp.2026.100141Global mortality and DALY burden across major disease categories, 1990–2021: trends, SDI-related distribution, and drivers of DALY changes
Jinli Liu, Zhonglin Chai, Gang Chen, Lei Si et al.
2026-09 · DOI: 10.1016/j.medp.2026.100160Erratum to “The diagnostic accuracy of physical signs: practice experience compared with research evidence” [Medicine Plus 2 (2025)100093]
Xiaxiao Yan, Yuelun Zhang, Yirong Xiang, Leyin Xu et al.
2026-06 · DOI: 10.1016/j.medp.2026.100132Circadian rhythms in cardiovascular disease: a new perspective on inter-organ crosstalk
Longkun Liu, Yajie Cai, Mengmeng Zhu, Yanfei Liu et al.
2026-06 · DOI: 10.1016/j.medp.2026.100140PLD4 mutations and SLE: insights from genetic and functional studies to clinical precision treatment
Danna Xu, Yun Zhang
2026-06 · DOI: 10.1016/j.medp.2026.100134Survival after kidney-sparing surgery versus radical nephroureterectomy for ureteral urothelial carcinoma: a SEER-based propensity score-matched cohort study
Rui Chen, Yuxuan Song, Chen Wang, Yang Liu et al.
2026-06 · DOI: 10.1016/j.medp.2026.100145The prevalence of comorbidities and the metabolic control status in patients with diabetes mellitus in Guangdong Province of China: a cross‐sectional study
Xuanrong Chen, Hongrong Deng, Yanling Yang, Wei Jiang et al.
2026-06 · DOI: 10.1016/j.medp.2026.100144VDAC2 deficiency: a new target for cancer immunotherapy and regulation of inflammatory responses
Yutian Fu, Fengbin Gao, Yanlan Yu
2026-06 · DOI: 10.1016/j.medp.2026.100139Deep learning for predicting lymph node metastasis in T1b gastric cancer using histopathology: a retrospective, multicenter study
Linbin Lu, Jun Yu, Yan Zhang, Ning Han et al.
2026-06 · DOI: 10.1016/j.medp.2026.100143Reviews
Community Reviews
Version History
October 4, 2026 at 9:21 pm
October 2, 2026